Source: Biospectrum Asia

Astellas: Astellas pushes translational and clinical oncology research in Japan

Astellas and Japanese Foundation for Cancer Research partner to accelerate translational and clinical oncology research

Read full article »

Astellas's Competitors | Astellas's News | Astellas's Financials

Followers on Owler

4,009

Annual Revenue

$10-50B

Employees

10-50K

President & CEO

Naoki Okamura

CEO Approval Rating

67/100

Astellas Pharma is a Japan-based multinational pharmaceutical company that develops and commercializes novel therapeutics for the treatment of a range of diseases.